Ceramic-ceramic articulation surface implants

Information

  • Patent Grant
  • 8123812
  • Patent Number
    8,123,812
  • Date Filed
    Thursday, August 27, 2009
    15 years ago
  • Date Issued
    Tuesday, February 28, 2012
    12 years ago
  • Inventors
  • Original Assignees
  • Examiners
    • Isabella; David
    • Stroud; Jonathan R
    Agents
    • Mintz, Levin, Cohn, Perris, Glovsky and Popeo PC
Abstract
A prosthesis for articulation (e.g., hip or joint prosthesis) is provided, which includes a pair of articulation components respectively defining a pair of articulation surfaces movably engageable with each other. In some embodiments, each of the articulation surfaces is formed from a biocompatible ceramic (e.g., doped silicon nitride ceramic) having a flexural strength greater than about 700 Mega-Pascal (MPa) and a toughness greater than about 7 Mega-Pascal root meter (MPam0.5).
Description
BACKGROUND OF THE INVENTION

This invention relates generally to improvements in articulating joint prostheses, particularly such as an improved prosthetic hip joint or the like. More specifically, this invention relates to a combination of an improved ceramic material articulating against a well known and established metal for use in a metal-ceramic composite articulation which exhibits long wear characteristics with substantial elimination of wear debris, and which further exhibits reduced in-vivo fracture risk. Additionally, this invention is also related to the ability to use metal femoral heads with ceramic acetabular liners. The specific clinical benefits of this feature stem from the ability to use fracture resistant heads with low wear and substantial wear debris elimination, the use of large head diameters, which greatly facilitates minimizing risk of dislocation of the head from the prosthetic joint, and providing surgeons and patients with the choice of using this combination for revision of failed joint prostheses.


Typical articulating joints, which consist of a metal surface articulating with a ultra-high molecular weight polyethylene (PE) are inadequate. Clinical studies have shown that the principal cause of implant failure is osteolysis secondary to wear of the implant bearing-surfaces. The primary cause appears to be particulate debris in the form of ultra-high molecular weight polyethylene (PE) released, for example, from the PE acetabular liner bearing of a hip prosthesis1. Such PE wear debris when released into the peri-implant tissues appears to elicit a deleterious biologic reaction, incorporating foreign-body giant cell and macrophage cell responses leading to bone resorption, and eventual loosening of the prosthetic implant. As a consequence, alternative rigid-on-rigid bearing materials such as ceramic-on-ceramic (C-C) (such as alumina), metal-on-metal (M-M), and the recent cobalt chrome alloy (CoCr)—heavily cross linked PE (XPE) are being introduced.


Clinical experience from 1983 to the present has encompassed over two million alumina ceramic femoral-head implants.2,3 Total hip replacement studies incorporating both CoCr and alumina ceramic heads have established the superiority of ceramic-PE couples over metal-PE couples, with alumina-alumina couples demonstrating 2-3 orders lower wear volume than the best ceramic-PE couples.4 Even so, the major limitation to use of alumina ceramics today is the likelihood of brittle fracture, even in just a low incidence of 2% or less. From the limited series of clinical studies available in the United States, the failure incidence of alumina heads was found to be surprisingly high and of quite short follow-up periods, anywhere from 9 months to 10 years.”6,5 Thus the fracture incidence in ceramics is still of clinical concern. Typical ceramic materials have low toughness and are prone to failure by brittle fracture. As history has indicated, there is an urgent need to find an improvement to alumina, particularly with ceramic-ceramic couples which have higher bearing contact stresses.6


Low wear of articulating components occurs when the mating surfaces have comparable and high hardness, good surface finish, conformal surface geometry, compatible mechanical properties and a low coefficient of friction. It is because of the first three conditions that ceramic-ceramic couples have demonstrated very low wear. Contact damage results in the weaker material when the moduli and hardness of the articulating surfaces are very different, as is the case for CoCr-PE or even zirconia or alumina ceramic-PE. An ideal articulating low wear couple will have closely matching properties and high toughness. Traditional ceramics such as alumina are prone to brittle fracture owing to their low toughness. Such brittle failure in ceramic materials results from propagation of microcracks initiated at and just below the surface. Other ceramic materials such as zirconia, zirconia toughened alumina or Si3N4 that have higher toughness have significantly higher reliability than alumina, owing to the ability to avoid catastrophic failure. Specifically, using such ceramics can allow significant improvements in wear properties along with improved reliability. The specific advantages can be illustrated by considering the articulating hip joint. If the articulating hip joint can be made with a metal femoral head and a ceramic acetabular cup, additional significant clinical benefits can be obtained as listed below:

    • The metal femoral head does not fail catastrophically as ceramic heads can, assuring patient safety;
    • The metal head can be made of a larger size, up to 44 mm diameter, than ceramic heads can typically be made, providing the surgeon greater flexibility in implant size selection; and
    • The metal head can be used as both a primary hip prosthesis or a revision hip prosthesis.


This invention describes a Si3N4 acetabular cup-CoCr femoral head couple. This couple is superior to other ceramic-metal couples such as alumina-metal,7,8,9 owing to compatible properties such as hardness, tensile strength, elastic modulus, high fracture toughness, and lubricity. Si3N4 also has an optimal combination of toughness and strength properties that gives superior damage resistance: the ability to retain strength following contact damage. Friction property studies of Si3N4 ceramics show that Si3N4-(M-50) steel hybrid bearings and Si3N4—Si3N4 bearings had the lowest friction coefficients under both lubricated and dry conditions of the materials tested. In contrast, alumina ceramic-ceramic and alumina-steel bearings had approximately three times the friction coefficient when tested under similar conditions.


It is therefore an object of this invention to provide a new set of bio-compatible articulating surface materials for use in prosthetic joints which will have:

    • Ultra-low wear with volumetric wear rates of less than 1 mm3/10 million cycles;
    • Long in-vivo life;
    • Wide range of sizes maximizing surgeon choice and optimizing fit to patient anatomy;
    • Wide bio-mechanical margin of safety for all sizes, minimizing risk of in-vivo fracture;
    • Preserving modularity of prosthetic articulating joint designs; and
    • Allowing both primary and revision prosthetic articulating joint designs.


SUMMARY OF THE INVENTION

In accordance with the invention, an improved joint prosthesis such as a hip, knee or shoulder joint or the like is provided with articulation between a first component and a second component, wherein at least one of these joint components is formed from a selected ceramic material designed for high fracture toughness or resistance, and further wherein the assembled joint components are designed for long-term articulation with minimal wear and resultant minimal production of undesired wear debris. The first component has an articulation surface formed from a bio-compatible ceramic with enhanced flexural strength and toughness properties, and wear properties compatible with the second component which has an articulation surface formed from a bio-compatible ceramic with enhanced flexural strength and toughness properties, or from a metallic alloy.


For example, in one embodiment, an implantable articulating bone prosthesis (e.g., hip or joint prosthesis) is provided, which includes a pair of articulation components respectively defining a pair of articulation surfaces movably engageable with each other. In some embodiments, each of the articulation surfaces is formed from a biocompatible ceramic (e.g., doped silicon nitride ceramic) having a flexural strength greater than about 700 Mega-Pascal (MPa) and a toughness greater than about 7 Mega-Pascal root meter (MPam0.5).


In a preferred form, the first component of the articulatory prosthesis is formed from a silicon nitride ceramic material doped with other oxides such as yttrium oxide and alumina. Other dopants can include magnesium oxide, or strontium oxide.


Other features and advantages of the invention will become more apparent from the following detailed description taken in conjunction with the accompanying drawings which illustrate, by way of example, the principles of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings illustrate the invention. In such drawings;



FIG. 1 is a graph illustrating the results of three point bend testing for Si3N4 ceramic test samples;



FIG. 2 is a graph illustrating the fracture toughness of the Si3N4 ceramic test samples depicted in FIG. 1;



FIG. 3 is a graph showing wear test results for simulated hip prostheses using Si3N4 ceramic acetabular cup and femoral heads (Si3N4 ceramic-Si3N4 ceramic, Stations 1 and 2), and a Si3N4 ceramic acetabular cup and CoCr metal femoral head (Si3N4 ceramic-metal, Station 3); and



FIG. 4 is a graph showing wear performance of Si3N4 ceramic acetabular cup and ceramic femoral head components (Si3N4 ceramic-Si3N4 ceramic), and Si3N4 ceramic cup and metal (Si3N4 ceramic-metal) head hip prostheses through an extended wear cycle, in comparison with metal-to-metal and traditional ceramic-to-ceramic in-vitro wear data.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Powders of Si3N4 and dopants such as alumina, yttria, magnesium oxide, and strontium oxide were conventionally processed to form a doped composition of silicon nitride. The dopant amount was optimized to achieve the highest density and mechanical properties. The homogeneous powders were then cold isostatic pressed at 300 Mega-Pascal (MPa) followed by sintering in a controlled atmosphere. Some cold isostatically pressed bars were hot isostatically pressed. A sintering temperature of 1875° C. was found optimal to achieve high density, absence of pores and other flaws and a uniform fine-grained microstructure. The best combination of density and mechanical properties was achieved with Si3N4 doped with 6 weight % Y2O3+4 weight % Al2O3.


Flexural strength was measured on standard 3-point bend specimens per American Society for Testing of Metals (ASTM) protocol method C-1161 and fracture toughness measured using single edge notched beam specimens per ASTM protocol method E399. Bend tests were conducted using test fixtures designed to minimize spurious stresses, with a nominal span of 40 mm. The bending load was applied using a universal testing machine at a cross-head displacement speed of 0.5 mm/min. At least 6 bars were tested to get a measure of the distributions and the Weibull modulus. The composition/process that gave the highest fracture toughness, Weibull modulus and damage resistance was selected for fabricating 28 mm hip prosthesis implant articular femoral head and acetabular cup components. 28 mm CoCr metal femoral heads were obtained from Biomet, Inc. of Warsaw, Ind.


Wear performance tests of up to 1 million cycle duration were conducted. Wear detection was primarily done gravimetrically with some inspection of the surfaces for wear track analysis and wear debris analysis using scanning electron microscopy. In the hip prosthesis simulator test, the rotating cams (uni-directional) carrying the specimen chambers were driven at 1 Hz frequency through +23° arcs on orthogonal axes. Each vertical load column had a self alignment device and friction torque sensors. In addition, both the anti-rotation peg and the friction sensor pegs were guide mounted on rollers to provide continuous constraint. For this study, the cam rotation was synchronized with the hip-joint loading. The “Paul” physiologic load profile was used.10,11 All tests were run at 2 KiloNewton (kN) peak load/0.2 kN minimum load. The test cups were arranged in an anatomically inverted position in the hip prosthesis simulator. A solution of 90% bovine serum was used as the lubricant with 10% standard additives of sodium azide and ethylene diamine tetra-acetic acid (EDTA). The specimen chambers were replenished with distilled water during the tests. Lubricant temperature was monitored but not controlled since the lubricant's bulk temperatures run in the range 36-40° C., close to body temperature. The ceramic cups were not sterilized prior to test. Soak control cups were not used for the ceramic-ceramic and ceramic-metal wear tests. The diametral clearance, surface finish and sphericity tolerance was noted. Component wear was determined using a gravimetric method. Wear components were cleaned and dehydrated and each set weighed four times in order with a 32 mm CoCr head as a calibration standard. The overall volumetric wear rate was determined by the slope of the linear regression line. A consistent wear rate, i.e. gradient of the linear regression trend was deemed more significant than the actual magnitude of the wear at any point in time.


Microstructural features such as grain size, pore size, porosity and defects were observed on sintered Si3N4 specimens after etching with carbon tetra-fluoride plasma. The specimens were found to be dense, with no detectable porosity, and had substantially uniform grain size consistent with high quality ceramics.


For fracture toughness testing, 2.5 mm×5 mm×25 mm bar specimens with varying notch depth, a, were prepared. The prepared specimens were tested in three-point bending with a span length of 20 mm. The resultant fracture loads were converted to fracture toughness values using ASTM protocol method E399. The fracture strength and toughness values are given in Table 1, and are plotted in FIGS. 1 and 2. As expected, hot iso-statically pressed specimens labeled as SNH and SNH-1 exhibited high strength, toughness and Weibull moduli. Hence hot iso-static pressed components were fabricated into acetabular and femoral components. The relevant mechanical characterization data obtained are tabulated in Table 1.









TABLE 1







Weibull Modulus and Characteristic Fracture Strength of Si3N4.












Characteristic




Weibull
Strength
Fracture Toughness


Material
Modulus M
σf (MPa)
Klc (MPam0.5)





SNH
34.9
853
9.10 (0.66)


SNH-1
19.1
952
9.61 (0.95)









The results indicate that SNH and SNH-1 have a substantially optimized high flexural strength, greater than about 900 MPa, and fracture toughness, greater than about 9 MPam0.5.


A trial wear test using a hip simulator was conducted using Si3N4 acetabular cups articulating against Biomet's standard 28 mm CoCr metal femoral heads (previously identified). Three Biomet 28 mm heads were used. The mating Si3N4 acetabular ceramic cups were ground without lapping. The surface roughness value (Ra) value was ˜0.5 μm. High wear of the metal femoral heads was observed, attributed to the higher surface roughness, which resulted in scouring the surface of the CoCr metal femoral heads. The wear behavior was found to be linear and typical of 3-body wear, dominated by unstable characteristics. The lubricant solution exhibited the concomitant amount of CoCr metal debris. Further, the wear tracks showed non-polar contact rather than polar contact as anticipated from the low diametral clearance. Fine scratch marks and wear tracks were observed midway between the pole and equator, while the pole had a shiny sheen, indicative of equatorial contact.


For subsequent wear tests, the Si3N4 acetabular and femoral components were ground and lapped to obtain an Ra<0.05 μm. The diametral clearance and sphericity was also varied. The CoCr metal femoral heads were made from a wrought high carbon CoCr alloy containing about 64 weight % cobalt, about 28% weight chromium, about 6% weight molybdenum, about 0.5% weight manganese, about 0.25% weight iron, about 0.2% weight nickel, about 0.2% weight nitrogen and about 0.23% weight carbon. The conventional low carbon CoCr alloy had a similar elemental weight composition with a carbon content of about 0.06% by weight. Such CoCr alloys used for joint prostheses are wrought alloys conforming to ASTM Specification 1537. This high carbon alloy had an elastic modulus greater than 210 giga Pascal (GPa), which had a closer modulus match to the doped Si3N4 ceramic (elastic modulus ˜300 GPa) compared to the low carbon CoCr alloy used in the trial run. The Vickers hardness of these alloys is in the range of 4-5 GPa compared to between 14-16 GPa Si3N4. The elastic modulus and hardness of the articulating surfaces of the doped Si3N4 ceramic-Si3N4 ceramic or the doped Si3N4 ceramic-CoCr alloy pair are better matched compared to either CoCr-PE, or CoCr-XPE articulations. This was expected to result in better wear performance.


Relevant design data pertaining to the articulating femoral head and acetabular cup pairs chosen for the wear study are tabulated in Table 2. Stations 1 and 2 had Si3N4 ceramic acetabular cup-Si3N4 ceramic femoral head bearings, and Station 3 had a Si3N4 ceramic acetabular cup-CoCr metal femoral head bearing. For the Si3N4 ceramic-Si3N4 ceramic bearings in Stations 1 and 2, a 70 and 100 μm diametral clearance was chosen to test the effect of run-in wear. The sphericity tolerance of the ceramic acetabular cups was between 1-1.5 μm in all cases and was less than 0.5 μm for both the ceramic femoral heads. For the Si3N4 acetabular cup-CoCr femoral head bearing, a diametral clearance of about 200 μm was selected.









TABLE 2







Design Tolerances for the Second Wear Performance Test.














Surface





Diameter
Roughness,
Sphericity



Components
(mm)
Ra (μm)
(μm)





Station 1
Ceramic Cup
28.0734
0.0390
1.486



Ceramic Head #4
27.9704
0.0440
0.419













Diametral Clearance
103
μm













Station 2
Ceramic Cup
28.0552
0.0074
1.448



Ceramic Head #2
27.9856
0.0447
0.851













Diametral Clearance
69.6
μm













Station 3
Ceramic Cup
28.0252
0.0091
1.041



CoCr Head 743650 C
27.7986
0.0149
3.785













Diametral Clearance
226.6
μm











The results from the wear test are plotted in FIG. 3. Stations 1 and 3 with diametral clearance of about 100 and 225 μm showed ultra low wear, with no observable run-in wear. In contrast, Station 2 with a low diametral clearance of about 70 μm showed classic biphasic behavior as is typical for metal-metal and ceramic-ceramic bearings. This biphasic behavior is attributed to the lower diametral clearance which, owing to inadequate film lubrication between the articulating surfaces, results in run-in wear.


Comparing the wear performance of the silicon nitride ceramic-ceramic bearings in Stations 1 and 2, it was noted that the bearing in Station 2 exhibited a “grinding” noise along with an increase in lubricant temperature during the run-in period. Following the run-in period, both Stations 1 and 2 behaved normally, with very low steady state wear rates. This was attributed to the lower diametral clearance used in Station 2, which may have resulted in an inadequate lubricant film to be developed between the femoral head and acetabular cup. The wear performance of the Si3N4 acetabular ceramic cup-CoCr metal femoral head bearing was characterized by an absence of run-in wear, similar to that of Station 1, and very low steady state wear rates. This result was as anticipated where, with better modulus matching, a ceramic-metal articulation couple could provide a ultra-low wear alternative for total hip arthroplasty.


The wear performance of these bearings was obtained over a 4 million cycle period. The weight loss data obtained were converted to volumetric wear rates and extrapolated to 10 million cycles to enable a comparison to literature values. The data, plotted in FIG. 4, indicate that the Si3N4 femoral head-Si3N4 acetabular cup bearings and the Si3N4 acetabular cup-CoCr metal femoral head show ultra-low wear of 0.65 mm3/10 million cycles and 3.4 mm3/10 million cycles respectively. In comparison, wear rates of 62 mm3/10 million cycles for CoCr-PE (clinical data), 6.5 mm3/10 million cycles for metal-metal (in-vitro) wear and 0.35-0.6 mm3/10 million cycles for alumina ceramic-alumina ceramic (in-vitro) have been reported.


Observation of the articulating components after 1 million cycles of wear testing, validated the ultra-low wear behavior by exhibiting a complete absence of wear tracks or other wear patterns. The articulating surfaces retained their high shine, consistent with the negligible weight loss observed for the components.


The above-described optimized material properties of Si3N4 have demonstrated a 100% increase of fracture toughness over alumina, and a 50% increase in fracture strength over alumina ceramics, which typically have a fracture toughness of about 5 MPam0.5 and a flexural strength of about 600 MPa. These properties of Si3N4 can allow the manufacture of total hip arthroplasty implants and other prosthetic joint implants such as knee and shoulder joints with significantly higher safety and reliability. Wear performance of Si3N4 femoral head-Si3N4 acetabular cup components and Si3N4 acetabular cup-CoCr femoral head components indicates that these bearings are better than metal-metal bearings and comparable to ceramic-ceramic bearings, with a volumetric wear rate of 2 orders of magnitude lower than CoCr-PE and 20 times lower than CoCr-XPE bearings.


The combination of the metal femoral head and a ceramic acetabular cup described above offers unprecedented benefits owing to inherent fracture resistance and excellent wear performance. The fracture resistance is derived from the use of metal femoral heads instead of ceramic femoral heads. It is well known from finite element analyses of the stresses in hip prosthetic joints that the femoral head component is subjected to high tensile stresses. Historically, such tensile stresses have been implicated in ceramic head fracture. Metal femoral heads do not fracture owing to the ductile nature of metals. Hence use of metal heads avoids fracture risk. In contrast, the acetabular cup component is typically subjected mainly to compressive stresses, which ceramics are designed to withstand. Furthermore, the combination of high toughness and flexural strength provides improved capability to withstand loads. Thus, as a general design principle for articulating prosthetic joints, the articulating component subjected to the higher tensile stresses can be made from a metal and the mating articulating component subjected to the higher compressive stresses can be made from the high strength high toughness ceramic with favorable tribiological properties. To illustrate this by way of example, in the hip joint, the femoral head can be made of metal and the mating acetabular cup can be made of the ceramic. In the case of knee joints, the condylar component which is subjected to higher tensile stresses, can be made from metal while the mating tibial component can be made from the ceramic. Similarly, the concept can be extended to other articulating prosthetic joints such as the shoulder joint.


The use of Si3N4 femoral head-Si3N4 acetabular cup components and Si3N4 acetabular cup-CoCr femoral head components in the instant invention to demonstrate the concept of using a fracture resistant metal alloy articulating with optimized ceramics to obtain an ultra low wear joint are illustrative of the general concept. Alternate metal alloys suitable for medical implants such as zirconium based alloys, titanium based alloys or stainless steel alloys may be used for the femoral head of a hip joint (or the component subjected to higher tensile stresses). Alternate enhanced toughness ceramic materials such as doped zirconia or zirconia toughened alumina could also be used for the acetabular component of a hip joint (or the component subjected to higher compressive stresses). This concept can also be applied to other orthopedic joints such as the shoulder or knee joint.


A variety of further modifications and improvements in and to the invention will be apparent to those persons skilled in the art. Accordingly, no limitation on the invention is intended by way of the foregoing description and accompanying drawings, except as set forth in the appended claims.


LITERATURE CITED



  • 1. Callaway G. H., Flynn W., Ranawat C. S., and Sculco T. P., J. Arthroplasty, 10, No. 6:855-859, 1995.

  • 2. Willman G., Pfaff H. G., and Richter H. G., Sonder. aus BioMed. Technik, 40, 12, pp. 342-346, 1995.

  • 3. Clarke I. C. and Gustafson A., 6th Biomat. Symp. Implant Matls. In Orthop. Surg., ed. H. Willert and G. Buchorn, Gottingen University, Germany, in press, 1995.

  • 4. Clarke I. C. and Gustafson A., In Press, Intl. Ceramics Congress, Otsu City, Japan, November 1997.

  • 5. Mangione, P. Pascarel, X., Vinciguerra B, and Honton J. L., Intl, Orthop., 18, pp. 359-362, 1994.

  • 6. Holmer P. and Nielsen P. T., J. Arthrop., 8, 567, 1993.

  • 7. B. Bhushan and L. B. Sibley, “Silicon Nitride Rolling Bearings for Extreme Operating Conditions”, ASME Trans. 25, 4, pp. 417-428, 1981.

  • 8. D. L. Allen, “Effect of Composition and Physical Properties of Silicon Nitride on Rolling Wear and Fatigue Performance”, Tribology trans., Vol. 37, 2, pp. 410-414, 1994.

  • 9. J. W. Lucek, “Rolling Wear of Silicon Nitride Bearing Materials”, ASME Gas Turbine and Aeroengine Congress and Expo., Brussels, Belgium, 1990.

  • 10. Clarke I C, McKellop H A, Okuda R, McGuire P, Young R, and Hull D, “Materials and prosthesis design criteria—hip simulator studies”, Trans. 28th Ann. ORS, New Orleans, pp. 292, 1982.

  • 11. McKellop H and Clarke I. C., “Degradation and wear of Ultra-High Molecular-Weight Polyethylene” In American Society for Testing & Materials, ASTM STP 859:351-368, 1985.


Claims
  • 1. A prosthesis for articulation, comprising: a first component of a joint prosthesis for articulation having a first ceramic articulation surface; anda second component of the joint prosthesis for articulation having a second ceramic articulation surface for articulation with the first ceramic articulation surface,wherein at least one of the first ceramic articulation surface and the second ceramic articulation surface comprises biocompatible doped silicon nitride ceramic having a flexural strength greater than about 700 Mega-Pascal (MPa) and a toughness greater than about 7 Mega-Pascal root meter (Mpam0.5), and wherein the doped silicon nitride ceramic comprises one or more dopants selected from the group of dopants consisting of yttrium oxide, magnesium oxide, strontium oxide, and alumina.
  • 2. The prosthesis of claim 1 wherein the biocompatible doped silicon nitride ceramic has a toughness greater than about 9 Mega-Pascal root meter (Mpam0.5).
  • 3. The prosthesis of claim 1 wherein each of the first ceramic articulation surface and the second ceramic articulation surface comprises a biocompatible ceramic having a flexural strength greater than about 700 Mega-Pascal (MPa) and a toughness greater than about 7 Mega-Pascal root meter (Mpam0.5).
  • 4. The prosthesis of claim 1, wherein the first ceramic articulation surface is generally concave.
  • 5. The prosthesis of claim 4, wherein the second ceramic articulation surface is generally convex.
  • 6. The prosthesis of claim 1, wherein the biocompatible doped silicon nitride ceramic comprises aluminum oxide.
  • 7. The prosthesis of claim 1, wherein the biocompatible doped silicon nitride ceramic comprises yttria.
  • 8. The prosthesis of claim 1, wherein the biocompatible doped silicon nitride ceramic comprises aluminum oxide and yttria.
  • 9. The prosthesis of claim 1 wherein the biocompatible doped silicon nitride ceramic does not include strontium oxide.
  • 10. The prosthesis of claim 1 wherein each of the first component and the second component consists essentially of the doped silicon nitride ceramic.
  • 11. The prosthesis of claim 1, wherein the prosthesis comprises a hip joint prosthesis.
  • 12. The prosthesis of claim 1, wherein the prosthesis comprises a knee joint prosthesis.
  • 13. The prosthesis of claim 1, wherein the prosthesis comprises a shoulder joint prosthesis.
  • 14. A prosthesis for articulation, comprising: a first component of a joint prosthesis for articulation having a first ceramic articulation surface; anda second component of the joint prosthesis for articulation having a second ceramic articulation surface for articulation with the first ceramic articulation surface,wherein at least one of the first ceramic articulation surface and the second ceramic articulation surface comprises biocompatible doped silicon nitride ceramic, and wherein the doped silicon nitride ceramic comprises one or more dopants selected from the group of dopants consisting of yttrium oxide, magnesium oxide, strontium oxide, and alumina.
  • 15. The prosthesis of claim 14, wherein the biocompatible doped silicon nitride ceramic comprises aluminum oxide.
  • 16. The prosthesis of claim 14, wherein the biocompatible doped silicon nitride ceramic comprises yttria.
  • 17. The prosthesis of claim 14, wherein the biocompatible doped silicon nitride ceramic comprises aluminum oxide and yttria.
  • 18. The prosthesis of claim 14 wherein the biocompatible doped silicon nitride ceramic does not include strontium oxide.
  • 19. The prosthesis of claim 14 wherein each of the first component and the second component consists essentially of the doped silicon nitride ceramic.
  • 20. The prosthesis of claim 14, wherein the first ceramic articulation surface is generally concave and wherein the second ceramic articulation surface is generally convex.
  • 21. The prosthesis of claim 1, wherein the biocompatible doped silicon nitride has a flexural strength of between about 700 MPa and 1000 MPa and a fracture toughness of between about 7 MPam0.5 and 10.5 MPam0.5.
  • 22. The prosthesis of claim 21, wherein each of the first component and the second component comprises the biocompatible doped silicon nitride ceramic.
  • 23. The prosthesis of claim 14, wherein the biocompatible doped silicon nitride has a flexural strength of between about 700 MPa and 1000 MPa and a fracture toughness of between about 7 MPam0.5 and 10.5 MPam0.5.
  • 24. The prosthesis of claim 21, wherein each of the first component and the second component comprises the biocompatible doped silicon nitride ceramic.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 10/987,415, filed on Nov. 12, 2004, now U.S. Pat. No. 7,666,229, which is a divisional of U.S. application Ser. No. 10/171,376, filed Jun. 13, 2002, now U.S. Pat. No. 6,881,229, which claims priority to U.S. Provisional Appln. 60/298,669, filed Jun. 14, 2001, all of which are hereby incorporated by reference herein in their entireties.

US Referenced Citations (141)
Number Name Date Kind
3867728 Stubstad et al. Feb 1975 A
4072532 Fletcher et al. Feb 1978 A
4327449 Charnley May 1982 A
4695282 Forte et al. Sep 1987 A
4743256 Brantigan May 1988 A
4759766 Buettner-Janz et al. Jul 1988 A
5092898 Bekki et al. Mar 1992 A
5098449 Hwang et al. Mar 1992 A
5152791 Hakamatsuka et al. Oct 1992 A
5158726 Saita et al. Oct 1992 A
5310408 Schryver et al. May 1994 A
5314477 Marnay May 1994 A
5330533 Walker Jul 1994 A
5401269 Buttner-Janz et al. Mar 1995 A
5425772 Brantigan Jun 1995 A
5462563 Shearer et al. Oct 1995 A
5464440 Johansson Nov 1995 A
5525557 Pujari et al. Jun 1996 A
5534001 Schlapfer et al. Jul 1996 A
5549693 Roux et al. Aug 1996 A
5549697 Caldarise Aug 1996 A
5549704 Sutter Aug 1996 A
5556815 Boberski Sep 1996 A
5641323 Caldarise Jun 1997 A
5697980 Otani et al. Dec 1997 A
5702453 Rabbe et al. Dec 1997 A
5702458 Burstein et al. Dec 1997 A
5782832 Larsen et al. Jul 1998 A
5785710 Michelson Jul 1998 A
5824100 Kester et al. Oct 1998 A
5826586 Mishra et al. Oct 1998 A
5871546 Colleran et al. Feb 1999 A
5871547 Abouaf et al. Feb 1999 A
5879404 Bateman et al. Mar 1999 A
5879407 Waggerner Mar 1999 A
5888223 Bray Mar 1999 A
5888226 Rogozinski Mar 1999 A
5899939 Boyce et al. May 1999 A
5904720 Farrar et al. May 1999 A
5908796 Pujari et al. Jun 1999 A
6013591 Ying et al. Jan 2000 A
6033438 Bianchi et al. Mar 2000 A
6037519 McKay Mar 2000 A
6039762 McKay Mar 2000 A
6039763 Shelokov Mar 2000 A
6069295 Leitao May 2000 A
6086588 Ameil et al. Jul 2000 A
6090144 Letot et al. Jul 2000 A
6110205 Nies Aug 2000 A
6113637 Gill et al. Sep 2000 A
6113638 Williams et al. Sep 2000 A
6123729 Insall et al. Sep 2000 A
6133180 Miyake et al. Oct 2000 A
6136029 Johnson et al. Oct 2000 A
6136369 Leitao et al. Oct 2000 A
6139585 Li Oct 2000 A
6149686 Kuslich et al. Nov 2000 A
6149688 Brosnahan et al. Nov 2000 A
6152960 Pappas Nov 2000 A
6156069 Amstutz Dec 2000 A
6179874 Cauthen Jan 2001 B1
6187701 Sekino et al. Feb 2001 B1
6210612 Pickrell et al. Apr 2001 B1
6235665 Pickrell et al. May 2001 B1
6261322 Despres, III et al. Jul 2001 B1
6261586 McKay Jul 2001 B1
6277149 Boyle et al. Aug 2001 B1
6281264 Salovey et al. Aug 2001 B1
6296667 Johnson et al. Oct 2001 B1
6302913 Ripamonti et al. Oct 2001 B1
6322895 Canham Nov 2001 B1
6344061 Leitao et al. Feb 2002 B1
6346123 McKay Feb 2002 B1
6368350 Erickson et al. Apr 2002 B1
6371988 Pafford et al. Apr 2002 B1
6376573 White et al. Apr 2002 B1
6398811 McKay Jun 2002 B1
6436137 Wang et al. Aug 2002 B2
6494883 Ferree Dec 2002 B1
6494915 Villar Gonzalez et al. Dec 2002 B1
6494917 McKellop et al. Dec 2002 B1
6511510 de Bruijn et al. Jan 2003 B1
6517580 Ramadan et al. Feb 2003 B1
6527810 Johnson et al. Mar 2003 B2
6540785 Gill et al. Apr 2003 B1
6540787 Biegun et al. Apr 2003 B2
6551995 Oppermann et al. Apr 2003 B1
6587788 Green Jul 2003 B1
6610097 Serbousek et al. Aug 2003 B2
6613091 Zdeblick et al. Sep 2003 B1
6641617 Merrill et al. Nov 2003 B1
6706068 Ferree Mar 2004 B2
6736849 Li et al. May 2004 B2
6740118 Eisermann et al. May 2004 B2
6743256 Mason Jun 2004 B2
6790233 Brodke et al. Sep 2004 B2
6818020 Sun et al. Nov 2004 B2
6846327 Khandkar et al. Jan 2005 B2
6881229 Khandkar et al. Apr 2005 B2
6908484 Zubok et al. Jun 2005 B2
6972037 Zubok et al. Dec 2005 B2
6972038 Zubok et al. Dec 2005 B2
6989030 Ohgushi Jan 2006 B1
6994728 Zubok et al. Feb 2006 B2
6994729 Zubok et al. Feb 2006 B2
6997954 Zubok et al. Feb 2006 B2
6997955 Zubok et al. Feb 2006 B2
RE39196 Ying et al. Jul 2006 E
7105030 Despres, III et al. Sep 2006 B2
20010047173 Schlapfer et al. Nov 2001 A1
20020062154 Ayers May 2002 A1
20020111680 Michelson Aug 2002 A1
20020143403 Vaidyanathan et al. Oct 2002 A1
20020161438 Scott et al. Oct 2002 A1
20030050709 Noth et al. Mar 2003 A1
20030097182 Buchman et al. May 2003 A1
20030114935 Chan et al. Jun 2003 A1
20030144664 Cavagna Jul 2003 A1
20030153984 Khandkar et al. Aug 2003 A1
20030233146 Grinberg et al. Dec 2003 A1
20040024462 Ferree et al. Feb 2004 A1
20040133281 Khandkar et al. Jul 2004 A1
20040143332 Krueger et al. Jul 2004 A1
20040172135 Mitchell Sep 2004 A1
20040176772 Zubok et al. Sep 2004 A1
20040176845 Zubok et al. Sep 2004 A1
20040220679 Diaz et al. Nov 2004 A1
20040225365 Eisermann et al. Nov 2004 A1
20040243126 Carbone et al. Dec 2004 A1
20040243241 Istephanous et al. Dec 2004 A1
20050033442 Fisher et al. Feb 2005 A1
20050055098 Zdeblick et al. Mar 2005 A1
20050060040 Auxepaules et al. Mar 2005 A1
20050079200 Rathenow et al. Apr 2005 A1
20050107888 Khandkar et al. May 2005 A1
20050177240 Blain Aug 2005 A1
20050216092 Marik et al. Sep 2005 A1
20050228382 Richelsoph et al. Oct 2005 A1
20050273176 Ely et al. Dec 2005 A1
20060052875 Bernero et al. Mar 2006 A1
20060142862 Diaz et al. Jun 2006 A1
Foreign Referenced Citations (8)
Number Date Country
0821922 Feb 1998 EP
WO 9947471 Sep 1999 WO
WO 9960956 Dec 1999 WO
0117464 Mar 2001 WO
03003950 Jul 2002 WO
WO 2004019828 Mar 2004 WO
WO 2004026186 Apr 2004 WO
WO 2004054479 Jul 2004 WO
Related Publications (1)
Number Date Country
20100049331 A1 Feb 2010 US
Provisional Applications (1)
Number Date Country
60298669 Jun 2001 US
Divisions (1)
Number Date Country
Parent 10171376 Jun 2002 US
Child 10987415 US
Continuations (1)
Number Date Country
Parent 10987415 Nov 2004 US
Child 12583940 US